A Persistent Itch Led to a Rare Cancer Diagnosis, Sparking a Mission for Awareness

What started as a persistent, nagging itch in a private area escalated into a life-altering diagnosis of invasive Extramammary Paget's disease (EMPD), a rare form of skin cancer. The journey from initial discomfort to advocating for others has been arduous, marked by months of misdiagnosis, invasive surgeries, and a profound need for greater awareness and research.

Initially dismissed as a common fungal infection like jock itch, the condition worsened over weeks and months. Over-the-counter treatments and even prescribed antifungal creams proved ineffective against the spreading, searing irritation. During a routine checkup, a doctor's quick examination also suggested a fungal infection, but a second physician’s opinion prompted a referral to a dermatologist.

Despite multiple visits to the dermatologist over a year and a half, and trying various treatments for conditions like eczema and contact dermatitis, the symptoms persisted and a small lesion appeared. It was only when the patient directly asked, "Would a biopsy help?" that the true nature of the illness was revealed. A punch biopsy confirmed the presence of invasive EMPD.

EMPD is a rare cancer, affecting an estimated one in a million to one in nine million people. It typically manifests as a scaly, itchy, or red patch in the genital, anal, or armpit areas. It shares similarities with Paget's disease of the breast but occurs outside of it. Its rarity makes diagnosis challenging, as many physicians may encounter few, if any, cases in their careers. The cancer can arise independently or as a sign of spread from another internal organ, making early detection critical.

This rare cancer primarily affects individuals over 40, with the average age of diagnosis around 65, though younger cases have been documented. While often slow-growing, its invasive nature poses a significant threat. The initial diagnosis marked the beginning of an intense struggle, including extensive surgery under general anesthesia that lasted an entire day. The procedure involved multiple rounds of tissue sampling and removal to ensure all cancer cells were eradicated, followed by reconstructive surgery using skin grafts.

Following the initial surgery and a period of recovery, the disease recurred. Over the next four years, the patient underwent multiple surgeries at various medical centers. The lack of standardized treatment protocols and challenges with healthcare system interoperability, where critical medical information was not seamlessly shared between institutions, added to the difficulty of his treatment journey. This fragmentation often left him responsible for piecing together his own medical history and repeating his story at every new appointment.

The profound isolation and lack of information surrounding EMPD spurred a personal mission. Recognizing the need for a centralized resource and a supportive community, he created an online platform and an associated support group. This initiative has grown into the largest online resource for EMPD, connecting patients and their families globally and providing a space for reliable information and mutual support.

Despite the personal toll, the patient has been cancer-free for five years. This experience has reinforced the importance of listening to one's body, advocating for oneself, and never taking health for granted. The patient's commitment to raising awareness aims to ensure that doctors recognize EMPD earlier, encourage further research into its causes and treatments, and help those diagnosed feel less alone in their fight.

Notable public figures have also been affected by EMPD; the actor and comedian Barry Humphries, known for his character Dame Edna Everage, reportedly battled the disease privately before his death in 2023. His story, like many others, highlights the silence that can accompany this illness, a silence the patient is determined to break.